Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • woodydon
    Member
    • Jan 2010
    • 52

    #1

    Cancer Exome-Seq data without matched Normal

    Dear all,

    I am aware of that tumor exome-seq data without matched normal will have difficulty for distinguishing somatic and germline mutations. I aim to find "important" somatic mutations from the data. I know incorporating 1000 genome project would help a bit. However, there are still too many mutations. Is there a way to redeem this kind of suffering?

    Thanks,
    Woody
    Last edited by woodydon; 07-17-2014, 10:11 PM.
  • woodydon
    Member
    • Jan 2010
    • 52

    #2
    Any suggestions?

    Comment

    • Richard Finney
      Senior Member
      • Feb 2009
      • 701

      #3
      Compare with known somatic mutations databases like "cosmic".

      Theoretically TCGA is supposed to produce known mutations; I don't know how reliable they are and how much is included in Cosmic.

      If you match a known mutation, then ... maybe probably.

      Novel mutation but not in dbSNP or 1000 genomes ... then maybe .... can't really be sure.
      There are probably somatic mutations in dbSNP.

      Comment

      • woodydon
        Member
        • Jan 2010
        • 52

        #4
        Originally posted by Richard Finney View Post
        Novel mutation but not in dbSNP or 1000 genomes ... then maybe .... can't really be sure.
        There are probably somatic mutations in dbSNP.
        Hi Richard,

        I like your comments. My tumor samples are a rare type of cancer which is not included in TCGA's collection. I have tried to substrate dbSNP and 1000 genomes (GMAF > 0), and I still have 194 mutations from 171 genes. The same 194 mutations co-existed in all three tumor samples. Therefore, I guess that most of them are germline mutations. But, it is possible that a few of them are important somatic mutations (SNP or indels).

        Thanks,
        Woody

        Comment

        • Baseless
          Member
          • Feb 2010
          • 31

          #5
          Like Richard, I'd first go for COSMIC, grab their gene list and look who is in there. Then filter for GMAF >15% in general population and head for potential meaninful stuff (start/stop codons, missense variants predicted harmful by SIFT/Polyphen, indels,...). If you have access to clinical information, check the genotypes. Something peculiar here? Take a look at the genes located in those regions (if you have to find those, ENSEMBL/Biomart is your friend). If you have anything useful regarding the phenotype, maybe check with clinvar or phenomizer to refine your candidate genes.
          And if everything fails, see if you can get a germline reference - remission sample, fibroblasts, oral swabs if necessary.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
            by SEQadmin2



            Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

            Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
            ...
            10-14-2026, 09:55 AM
          • SEQadmin2
            New Genomics Technologies Take Aim at Long-Standing Limits
            by SEQadmin2


            Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

            We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
            ...
            09-28-2026, 10:25 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 10-22-2026, 11:13 AM
          0 responses
          27 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-22-2026, 10:48 AM
          0 responses
          20 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-15-2026, 10:52 AM
          0 responses
          36 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-14-2026, 05:39 AM
          0 responses
          43 views
          0 reactions
          Last Post SEQadmin2  
          Working...